AzTrials
AzTrials

Arterial AneurysmSMCVNCT05714735

SMCV Assessment on Brain Swelling in Patients With SAH From Ruptured Artery Aneurysm

An observational study of Arterial Aneurysm, run by Xuanwu Hospital, Beijing at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Superficial cerebral veins findings in assessment of brain swelling in patients with aneurysmal subarachnoid hemorrhage who underwent intravenenous DSA examinations Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Arterial Aneurysm
What is being tested?
Cerebral Venography
Type of treatment
Surgery or procedure
How many people
198 participants
Where
1 siteChina
Study dates
1 Nov 2017to 30 Dec 2023
How long will I take part?
1 Year
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: patients with anterior circulation aneurysmal subarachnoid hemorrhage

Who may be able to join

  • age 18-70 years;
  • Hunt-Hess grade IV-V on admission; single aneurysm in the anterior circulation; interventional embolization of aneurysm is the first choice, and preoperative ventricular puncture drainage and intracranial pressure probe placement.

Who cannot join

  • Hunt-Hess grade I-III on admission;
  • patients with blood bubble-like aneurysm or accompanying intracranial hematoma who are not suitable for interventional embolization; those who directly choose craniotomy and clipping;
  • poor general condition or combined with pregnancy , malignant tumors, etc.

Trial locations and contacts

1 site in 1 country.

China1 site
  • The People Hospital of Shenzhen Baoan

    Shenzhen, Guangdong, 518000

Other trials in China

About this study

Official title: Assessment of Superficial Cerebral Venous Structures in Brain Swelling in Patients With Subarachnoid Hemorrhage From Anterior Communicating Artery Aneurysmal

Superficial cerebral veins findings in assessment of brain swelling in patients with aneurysmal subarachnoid hemorrhage who underwent intravenenous DSA examinations

Read the detailed description

Superficial cerebral veins findings in assessment of brain swelling in patients with aneurysmal subarachnoid hemorrhage who underwent intravenenous DSA examinations.To explore the relationship between the structure of middle and superficial cerebral veins in cerebral angiography and cerebral edema after ischemia-reperfusion of anterior circulation with large core infarction.

Being tested
Cerebral Venography
Keywords
Brain Swelling,Subarachnoid Hemorrhage,Artery Aneurysmal
Medical subject headings
Brain Edema

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cerebral VenographyRadiation

    Cerebral Venography Observation by DSA examinations

Study groups in NCT05714735
Study groupRoleWhat they receive
Whole-brain venographyCerevbral venography
Receives: Radiation: Cerebral Venography

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Death

    Death

    Measured: One year

  2. Bleeding events

    Intracerebral Hemorrhage

    Measured: One year

Secondary outcomes (1)
  1. Brain swelling

    Brain swelling score

    Measured: One year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Feb 2023
  2. Study start1 Nov 2017
  3. Primary completion7 Dec 2019
  4. Study completion30 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
198 participants (estimated)
Target duration
1 Year
IDs, dates and publications
ClinicalTrials.gov ID
NCT05714735
Sponsor's protocol ID
BAOAN SMCV in SAH
Acronym
SMCV
Status last verified
Jan 2023
First submitted
27 Jan 2023
Last updated
6 Feb 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Arterial Aneurysm, run by Xuanwu Hospital, Beijing at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Death (time frame: One year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in